Imaginostics CEO Speaks About Precision Medicine at New Labs + JLABS Series on Existential Medicine

Imagine treatments custom-tailored to the patient, rather than a one-size-fits-all approach. That was a key theme during Monday night’s precision medicine discussion at JLABS in New York City. Imaginostics CEO Dr. Codi Gharaghouzloo was one of four experts who served on the diverse panel. They discussed the current state of precision medicine and how the personalized medicine revolution impacts patient experience and clinical workflow.

The panel discussion was sponsored by New Labs and Johnson & Johnson Innovation, JLABS, along with EY. Additional panelists included:

• Olivier Elemento, PhD., Director of the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medicine
• Tammi Jantzen, Co-founder and CFO at Astarte Medical
• Adlai Goldberg, EY Global Life Sciences Digital, Social and Commercial Innovation Leader.

Event Details: https://www.eventbrite.com/e/existential-medicine-6-personalized-medicine-tickets-81344618945?aff=ey